MicroStrategy
MSTR
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Meritage Homes
MTH
US Stock MarketDetailed Quotes
ETNB 89bio
- 7.940
- +0.910+12.94%
Close Dec 20 16:00 ET
- 7.940
- 0.0000.00%
Post 20:01 ET
933.60MMarket Cap-2.68P/E (TTM)
7.950High6.600Low4.50MVolume7.030Open7.030Pre Close33.54MTurnover5.60%Turnover RatioLossP/E (Static)117.58MShares16.63052wk High2.47P/B638.38MFloat Cap6.43052wk Low--Dividend TTM80.40MShs Float47.253Historical High--Div YieldTTM19.20%Amplitude2.000Historical Low7.444Avg Price1Lot Size
About 89bio Company
89bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. Its product pipeline includes pegozafermin, FGF21, NASH, and SHTG. The company was founded on January 18, 2018 and is headquartered in San Francisco, CA.
Company Profile
SymbolETNB
Company Name89bio
Listing DateNov 11, 2019
Issue Price16.00
Founded2018
CEOMr. Rohan Palekar
MarketNASDAQ
Employees70
Fiscal Year Ends12-31
Address142 Sansome Street,2nd floor
CitySan Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94104
Phone1-415-432-9270
Websitehttp://www.89bio.com
Company Executives
- Name
- Position
- Salary
- Rohan Palekar
- Chief Executive Officer and Director
- 5.59M
- Dr. Hank Mansbach, M.D.
- Chief Medical Officer
- 2.54M
- Quoc Le-Nguyen
- Chief Technical Operations Officer and Head of Quality
- 2.51M
- Francis W. Sarena
- Chief Operating Officer
- --
- Ryan Martins
- Chief Financial Officer and Principal Accounting Officer
- --
- Dr. Steven M. Altschuler, M.D.
- Chairman of the Board
- 385.83K
- Martin Babler
- Director
- --
- Dr. Charles A. McWherter, PhD.
- Director
- --
- Dr. Derek DiRocco, PhD
- Independent Director
- 352.33K
- Lota S. Zoth, C.P.A.
- Independent Director
- 363.33K
- Kathleen D. Laporte
- Independent Director
- 360.17K
- Dr. Michael Hayden
- Independent Director
- 358.33K
- Dr. Edward Morrow Atkinson, III
- Independent Director
- 354.60K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
